- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06580548
A New At-home Telerehabilitation Care Service Delivery Model for Stroke Survivors in the Rio Grande Valley
March 12, 2026 updated by: Fadi Musfee, The University of Texas Health Science Center, Houston
The purpose of this study is to investigate the feasibility of a mobile telerehabilitation software for post-acute stroke care for Rio Grande Valley (RGV) stroke survivors with community health worker (CHW) at-home support and to estimate the functional health, mental health (depression), and caregiver burden outcomes of this new CHW-supported, at-home rehabilitation service delivery model and to identify salient barriers to and facilitators of adopting and delivering the new rehabilitation delivery model to further disseminate the model in real-world communities.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
11
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Texas
-
Houston, Texas, United States, 77030
- The University of Texas Health Science Center at Houston
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- A resident of the Brownsville, Texas (Cameron County) area
- SINGLE and FIRST qualifying stroke event with the ability to enroll and begin study activities within 3 months of onset of stroke event
- Pre-stroke modified Rankin score of ≤3 (less than moderate disability at baseline)
- Currently uninsured
- Spanish or English speaker
- Able to follow instructions (without aphasia that interferes with following instructions)
- Safe to perform basic strengthening rehabilitation exercises
- Able to stand with or without assistance
Exclusion Criteria:
- Aphasia or cognitive impairment (e.g., dementia) that interferes with following instructions or prevents following the study-related activities)
- Pre-stroke motor deficits
- Current psychiatric disorders, including substance use disorder
- Underlying brain pathologies inclusive of brain malignancies, multiple sclerosis
- Insured patients as insured patients are referred for standard-of-care clinical rehabilitation.
- Medical instability to participate in basic strengthening rehabilitation exercises
- Inability to access internet from home to access at-home rehabilitation software for intervention arm participants
- Having received any outpatient rehabilitation services prior to study enrollment for intervention arm participants
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: CHW-supported telerehabilitation plus Usual Care
|
Participants will receive the Mobile Rehab mobile software, which allows participants to be prescribed personalized rehabilitation strengthening video regimens electronically based on respondent-indicated mobility and activities of daily living functionality
Participants will be provide a list of local social services resources, including mental health, that participants can use .
A callback number will be provided if they have any questions about the services.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in basic mobility as assessed by the Acute Measure for Post-Acute Care (AM-PAC) Basic Mobility Outpatient Form (routine)
Time Frame: Baseline (week 1), week 3 (intervention participants only), week 6
|
This is an 18 item questionnaire and each is scored from 1(unable) to 4( none) for a score range of 1-72, higher score indicating better outcome
|
Baseline (week 1), week 3 (intervention participants only), week 6
|
|
Change in basic mobility as assessed by the Acute Measure for Post-Acute Care (AM-PAC) Basic Mobility Outpatient Form (low function )
Time Frame: Baseline (week 1), week 3 (intervention participants only), week 6
|
This is a 19 item questionnaire and each is scored from 0(unable) to 3( none) for a score range of 0-57, higher score indicating better outcome
|
Baseline (week 1), week 3 (intervention participants only), week 6
|
|
Change in basic activity as Acute Measure for Post-Acute Care (AM-PAC) Daily Activity Outpatient Short Form (routine)
Time Frame: Baseline (week 1), week 3 (intervention participants only), week 6
|
This is a 15 item questionnaire and each is scored from 1(unable) to 4( none) for a score range of 1-60, higher score indicating better outcome
|
Baseline (week 1), week 3 (intervention participants only), week 6
|
|
Change in basic activity as Acute Measure for Post-Acute Care (AM-PAC) Daily Activity Outpatient Short Form (low function)
Time Frame: Baseline (week 1), week 3 (intervention participants only), week 6
|
This is a 12 item questionnaire and each is scored from 0(total) to 3( none) for a score range of 1-36, higher score indicating better outcome
|
Baseline (week 1), week 3 (intervention participants only), week 6
|
|
Change in Health-related quality of life as assessed by the European Health-Related Quality of Life- 5 Dimensions (EQ-5D) EuroQoL-5D five-level survey (EQ-5D-5L)
Time Frame: Baseline, week 3 (intervention participants only), week 6
|
This is scored across 5 dimensions , mobility, self-care, usual activities, pain/discomfort, and anxiety/depression and each dimension is scored on a five-level severity ranking that ranges from 1 (no problems) to 5 (extreme problems), higher score indicating worse outcome
|
Baseline, week 3 (intervention participants only), week 6
|
|
Change in Depression as assessed by the Patient Health Questionnaire 9 (PHQ-9)
Time Frame: Baseline, week 3 (intervention participants only), week 6
|
This is a 9 item questionnaire and each is scored from 0(not at all) to 3(nearly every day) for a score range of 0-27, higher score indicating worse outcome
|
Baseline, week 3 (intervention participants only), week 6
|
|
Change in caregiver burden as assessed by the Zarit Burden Interview
Time Frame: Baseline, week 3 (intervention participants only), week 6
|
This is a 12 item questionnaire and each is scored from 0(never) to 4(nearly always) for a score range of 0-48, higher score indicating worse outcome
|
Baseline, week 3 (intervention participants only), week 6
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Acceptability/Appropriateness of the intervention for the stroke survivors as assessed by the Quantitative Implementation Measures for Stroke Survivors questionnaire
Time Frame: Baseline
|
This is an 8 item questionnaire and each is scored from 1( strongly disagree) to 5(strongly agree) for a score range of 1-40, higher score indicating better outcome
|
Baseline
|
|
Acceptability/Appropriateness of the intervention for the stroke survivors as assessed by the Quantitative Implementation Measures for Stroke Survivors questionnaire
Time Frame: week 7
|
This is an 8 item questionnaire and each is scored from 1( strongly disagree) to 5(strongly agree) for a score range of 1-40, higher score indicating better outcome
|
week 7
|
|
Adoption of the intervention for the stroke survivors as assessed by the Quantitative Implementation Measures for Stroke Survivors questionnaire
Time Frame: Baseline
|
This is an 5 item questionnaire and each is scored from 1( strongly disagree) to 5(strongly agree) for a score range of 1-25, higher score indicating better outcome
|
Baseline
|
|
Adoption of the intervention for the stroke survivors as assessed by the Quantitative Implementation Measures for Stroke Survivors questionnaire
Time Frame: week 7
|
This is an 5 item questionnaire and each is scored from 1( strongly disagree) to 5(strongly agree) for a score range of 1-25, higher score indicating better outcome
|
week 7
|
|
Acceptability & Appropriateness of the intervention for the community health workers as assessed by the Quantitative Implementation Measures for Community Health Worker questionnaire
Time Frame: Baseline
|
This is an 7 item questionnaire and each is scored from 1( strongly disagree) to 5(strongly agree) for a score range of 1-35, higher score indicating better outcome
|
Baseline
|
|
Acceptability & Appropriateness of the intervention for the community health workers as assessed by the Quantitative Implementation Measures for Community Health Worker questionnaire
Time Frame: week 7
|
This is an 7 item questionnaire and each is scored from 1( strongly disagree) to 5(strongly agree) for a score range of 1-35, higher score indicating better outcome
|
week 7
|
|
Adoption of the intervention for the community health workers as assessed by the Quantitative Implementation Measures for Community Health Worker questionnaire
Time Frame: Baseline
|
This is an 4 item questionnaire and each is scored from 1( strongly disagree) to 5(strongly agree) for a score range of 1-20, higher score indicating better outcome
|
Baseline
|
|
Adoption of the intervention for the community health workers as assessed by the Quantitative Implementation Measures for Community Health Worker questionnaire
Time Frame: week 7
|
This is an 4 item questionnaire and each is scored from 1( strongly disagree) to 5(strongly agree) for a score range of 1-20, higher score indicating better outcome
|
week 7
|
|
Feasibility of Community Health Worker as assessed by the Quantitative Implementation Measures for Community Health Worker questionnaire
Time Frame: Baseline
|
This is an 7 item questionnaire and each is scored from 1( strongly disagree) to 5(strongly agree) for a score range of 1-35, higher score indicating better outcome
|
Baseline
|
|
Feasibility of Community Health Worker as assessed by the Quantitative Implementation Measures for Community Health Worker questionnaire
Time Frame: week 7 (immediately after intervention)
|
This is an 7 item questionnaire and each is scored from 1( strongly disagree) to 5(strongly agree) for a score range of 1-35, higher score indicating better outcome
|
week 7 (immediately after intervention)
|
|
Feasibility as assessed by the number of participants enrolled
Time Frame: end of study (week 7)
|
end of study (week 7)
|
|
|
Adherence as assessed by the number of rehab videos watched in a day
Time Frame: end of study (week 7)
|
adherence is defined by ≥1 daily mobile rehab video usage
|
end of study (week 7)
|
|
Number of participants that view ≥1 daily mobile rehab videos
Time Frame: end of study (week 7)
|
end of study (week 7)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Fadi Musfee, MD, The University of Texas Health Science Center, Houston
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 17, 2025
Primary Completion (Estimated)
May 1, 2026
Study Completion (Estimated)
May 1, 2026
Study Registration Dates
First Submitted
August 29, 2024
First Submitted That Met QC Criteria
August 29, 2024
First Posted (Actual)
August 30, 2024
Study Record Updates
Last Update Posted (Actual)
March 16, 2026
Last Update Submitted That Met QC Criteria
March 12, 2026
Last Verified
March 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HSC-SPH-24-0166
- 1UM1TR004906 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
Mahidol UniversityNot yet recruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke SurvivorsThailand
-
Mahidol UniversityRecruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke PatientThailand
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
Samsung Medical CenterCompletedChronic Stroke | Subacute Stroke | ExoskeletonSouth Korea
-
Fondazione Don Carlo Gnocchi OnlusScuola Superiore Sant'Anna di Pisa; Fondazione Policlinico Universitario Campus...Not yet recruitingStroke | Stroke Hemorrhagic | Upper Limb Rehabilitation | Stroke IschemicItaly
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
Clinical Trials on CHW-supported telerehabilitation
-
Pamukkale UniversityCompletedTelerehabilitation | Juvenile Idiopathic Arthritis | Self-ManagementTurkey
-
Hacettepe UniversityCompleted
-
University of ValenciaCompleted
-
University of ValenciaRecruiting
-
Massachusetts General HospitalCompletedHypertension | Food Insecurity | Nutrition, Healthy | Community Health WorkerUnited States
-
Ari Johnson, MDHarvard Medical School (HMS and HSDM); University of California, San Francisco and other collaboratorsCompletedCommunity Health Worker Performance
-
Stockholm UniversityYale University; University of Chile; EDI Global; Elizabeth Glaser Pediatric AIDS... and other collaboratorsCompletedParenting | Early Child DevelopmentTanzania
-
University of FloridaNational Center for Advancing Translational Sciences (NCATS)Completed
-
University of MiamiHealth Choice Network; Center for Haitian StudiesCompletedCervical CancerUnited States
-
NYU Langone HealthNational Institute on Minority Health and Health Disparities (NIMHD)Enrolling by invitationHypertension | Diabetes Mellitus Type IIUnited States